Stockholm Stock Exchange | Large Cap
Sobi
+23.03%
Latest
+23.03%
3 months
Pareto SecuritiesRBCBerenbergSEBJefferiesSEB EquitiesDNB MarketsKepler CheuvreuxNordea MarketsCarnegieDeutsche BankMorgan StanleyHSBCRBC Capital MarketsDNBHandelsbanken Capital MarketsMorningstarDanske Bank MarketsDanske BankJefferies InternationalBarclaysHandelsbankenABG Sundal Collier

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia